Literature DB >> 17531813

Cdc18 enforces long-term maintenance of the S phase checkpoint by anchoring the Rad3-Rad26 complex to chromatin.

Damien Hermand1, Paul Nurse.   

Abstract

DNA replication is initiated by recruitment of Cdc18 to origins. During S phase, CDK-dependent destruction of Cdc18 occurs. We show that when DNA replication stalls, Cdc18 persists in a chromatin-bound complex including the checkpoint kinases Rad3 and Rad26. Rad26 directly binds Cdc18 and is required for Rad3 recruitment to chromatin. Depletion of Cdc18 when DNA replication is stalled leads to release of Rad3 and Rad26 from chromatin and entry into an aberrant mitosis even though replication intermediates can still be detected. These findings indicate that Cdc18 plays a pivotal role in checkpoint maintenance by anchoring the Rad3-Rad26 complex to chromatin. Cdc18 persistence during DNA-replication arrest requires the S phase checkpoint that inhibits the S phase CDK. We propose that S phase arrest activates the S phase checkpoint blocking mitosis onset and inhibiting Cdc18 degradation, and that the stabilized Cdc18, in turn, anchors Rad3 to chromatin to ensure long-term checkpoint maintenance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531813     DOI: 10.1016/j.molcel.2007.04.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  20 in total

1.  Distinct requirement of RNA polymerase II CTD phosphorylations in budding and fission yeast.

Authors:  Clément Cassart; Julie Drogat; Valérie Migeot; Damien Hermand
Journal:  Transcription       Date:  2012-09-01

Review 2.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

Review 3.  ATR signalling: more than meeting at the fork.

Authors:  Edward A Nam; David Cortez
Journal:  Biochem J       Date:  2011-06-15       Impact factor: 3.857

4.  Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors.

Authors:  Anton G Henssen; Casie Reed; Eileen Jiang; Heathcliff Dorado Garcia; Jennifer von Stebut; Ian C MacArthur; Patrick Hundsdoerfer; Jun Hyun Kim; Elisa de Stanchina; Yasumichi Kuwahara; Hajime Hosoi; Neil J Ganem; Filemon Dela Cruz; Andrew L Kung; Johannes H Schulte; John H Petrini; Alex Kentsis
Journal:  Sci Transl Med       Date:  2017-11-01       Impact factor: 17.956

5.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

6.  Deregulated Cdc6 inhibits DNA replication and suppresses Cdc7-mediated phosphorylation of Mcm2-7 complex.

Authors:  Lena R Kundu; Yuji Kumata; Naoko Kakusho; Saori Watanabe; Asako Furukohri; Shou Waga; Masayuki Seki; Hisao Masai; Takemi Enomoto; Shusuke Tada
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

7.  Cyclin E is stabilized in response to replication fork barriers leading to prolonged S phase arrest.

Authors:  Xiaoyan Lu; Jia Liu; Randy J Legerski
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling.

Authors:  Xin Xu; Sivaraja Vaithiyalingam; Gloria G Glick; Daniel A Mordes; Walter J Chazin; David Cortez
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

9.  Divergent S phase checkpoint activation arising from prereplicative complex deficiency controls cell survival.

Authors:  Eric Lau; Gary G Chiang; Robert T Abraham; Wei Jiang
Journal:  Mol Biol Cell       Date:  2009-07-08       Impact factor: 4.138

10.  Rad26p, a transcription-coupled repair factor, is recruited to the site of DNA lesion in an elongating RNA polymerase II-dependent manner in vivo.

Authors:  Shivani Malik; Priyasri Chaurasia; Shweta Lahudkar; Geetha Durairaj; Abhijit Shukla; Sukesh R Bhaumik
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.